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these genes until later stages of differenti-
ation. In either scenario, the complement
of transcription factors, rather than
lineage priming itself, may play a direct
role in HSC cell fate determination.
However, the two models may be distin-
guished by whether lineage priming
occurs concomitant with or subsequent
to cell fate decisions.
In this regard, the role of lineage priming
in segregation of the LMPP andMkE fates
remains to be resolved. Because Ikaros is
not required for development of LMPPs
but rather for lymphoid differentiation
from LMPPs, a possible role for
lymphoid-lineage priming appears to be
restricted to cell fate decisions after
segregation of the MkE fate (Ng et al.,
2009; Yoshida et al., 2006). However, it
remains possible that a critical Ikaros-
independent lymphoid gene(s) may func-
tion in repression of the MkE fate. It is
also unclear whether HSCs that coprime
lymphoid- and myeloid- along with
erythroid-lineage genes resolve these
conflicting gene expression programs or
whether they simply fail to undergo further
differentiation (Figure 1). Although the
degree of multilineage copriming appears
to be low in this study, this may be due to
the small number of genes examined.
Therefore, analysis of a larger set of
lineage-associated genes may reveal
a higher degree of copriming and a need
for resolution of conflicting gene expres-
sion programs at this stage. Acquisition
of the LMPP fate could be the conse-
quence of HSC differentiation concomi-
tant with a failure of MkE-lineage priming
(i.e., those cells that fail to activate MkE
genes become LMPPs). In this respect,
it is interesting that one of the primed
E lineage genes examined is Gata1,
a transcription factor that is essential for
E development whereas none of the
essential lymphoid transcription factors
are a component of the lymphoid-
lineage-primed set (Crispino, 2005). The
ability to analyze chromatin and global
gene expression patterns in single cells
is a challenging future goal that will be
required to understand how genome
regulation influences cell fate choices.
The identification of s-myly or other multi-
lineage gene programs in progenitors with
defined developmental potential is an
important step in understanding how
multiple lineages arise from HSCs.
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A wide variety of stimuli induce the inflammasome, but little is known about its role in immune protection
against viruses. In this issue of Immunity, Allen et al. (2009) and Thomas et al. (2009) describe a critical
role for NLRP3 induction of the inflammasome and protection against influenza virus infection.Influenza A virus is an important human
pathogen that infects millions of people
worldwide in seasonal epidemics and
leads to more than 30,000 deaths annu-
ally in the United States alone (Tauben-
berger and Morens, 2008). The character
of the immune response, and in particular
the innate immune response, is a key
determinant of influenza outcomewherein
innate immunity mediates our essential476 Immunity 30, April 17, 2009 ª2009 Elsevfirst-line defense against infection. Path-
ogen-associated molecular patterns
(PAMPs) present within influenza A virus
that are generated during infection are
recognized by three major classes of
pattern-recognition receptors (PRRs),
which form the basis for innate immune
detection of viruses and other microbes.
These PRRs include the Toll-like recep-
tors (TLRs), retinoic acid inducible gene-Iier Inc.(RIG-I)-like receptors (RLRs), and the
nucleotide-binding domain-leucine-rich
repeat-containing molecules (NLRs).
Detection of influenza A virus by TLRs or
RLRs lead to the production of type 1
interferons in bronchial epithelial cells
(via RIG-I) and plasmacytoid dendritic
cells (via TLR7) leading to tissue-specific
and systemic antiviral states (Wang
et al., 2007). In general, little is known
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virus infection and the induction of anti-
viral immune defenses.
TheNLR family contains 23members, of
which only a handful have been character-
ized in terms of their role as PRRs of
immune signaling (Franchi et al., 2009).
The first NLRs identified, NOD1 and
NOD2, are intracellular PRRs that detect
bacterial peptidoglycan leading to the
induction of NF-kB and MAP kinase
signaling pathways. Three other family
members NLRC4 (also known as IPAF),
NLRP1, and NLRP3 (cryopyrin and
NALP3) are intracellular proteins that form
distinct caspase-1-activating complexes
termed inflammasomes. NLRC4 responds
to bacterial flagellin and oligomerizes to
recruit caspase 1 via interactions between
the caspase activation and recruitment
domain (CARD) present on eachmolecule.
Caspase 1 is then autocatalytically cleaved
to its active form and is able to process
proIL-1b and proIL-18 into their respective
mature secreted forms, IL-1b and IL-18,
which operate to induce inflammation to
sites of infection and tissue damage. This
processing is the hallmark of inflamma-
some activity. NLRP1 responds to mur-
amyl dipeptide but does not contain a
CARD domain, so it relies on the adaptor
protein apoptotic speck-like protein con-
taining a CARD (ASC) to confer down-
stream signaling. NLRP3 also signals
through ASC and is reported to respond
to numerous stimuli including bacterial
DNA and RNA, pore-forming toxins, silica,
asbestos, uric acid, and ion flux. A role for
the NLRP3 inflammasome in response to
virus infection is also emerging. For
example, adenovirus DNA can stimulate
inflammasome signaling in a NLRP3-
dependent manner (Muruve et al., 2008).
Moreover, myxoma virus (a poxvirus)
encodes a protein that interferes with
ASC-mediated inflammasome signaling,
thus highlighting the importance of the in-
flammasome as a mediator of antiviral
activity (Johnstonetal., 2005). Inaprevious
study, Kanneganti et al. (2006) demon-
strated a role for NLRP3 in caspase 1 acti-
vation during virus infection of cultured
macrophages, and recent studies have
implicated a critical role for inflammasome
signaling in the adaptive immune response
against influenzaA virus infection (Ichinohe
et al., 2009). Now Allen et al. (2009) and
Thomas et al. (2009) show that NLRP3
plays anessential role to direct a protectiveinflammatory response that limits lung
damage and overall pathogenesis from
influenza A virus infection.
Allen et al. (2009) and Thomas et al.
(2009) both examined influenza A virus
infection in a mouse model wherein wild-
type mice and mice deficient in caspase
1 (Casp1/), ASC (Pycard/), NLRP3
(Nlrp3/), or NLRC4 (Nlrc4/) were
infected with a high but sublethal dose
of H1N1 influenza A virus strain A/PR/8/
34. Allen et al. (2009) found that although
70% of wild-type or Nlrc4/ mice
survived the virus challenge, only 40% of
Casp1/ or Pycard/ and only 20% of
Nlrp3/ mice survived the challenge.
This outcome supports a specific role for
the NLRP3-ASC-caspase 1 inflamma-
some in protection from influenza A virus
pathogenesis. Interestingly, histological
analysis of lung tissue from the infected
Nlrp3/ mice showed less infiltration of
inflammatory cells in the airway
compared to wild-type mice. This obser-
vation was confirmed by counting cells
present in bronchoalveolar lavage fluid
(BALF), a marker of acute inflammation,
which demonstrated an 50% reduction
in monocytes and neutrophils in the
Nlrp3/ animals compared to wild-type
or Nlrc4/ mice. Similarly, Thomas et al.
(2009) observed that infection under
similar conditions reduced survival from
70% in wild-type animals to 40% in
Nlrp3/ or Casp1/ animals. Likewise,
the number of neutrophils, monocytic,
and dendritic cells in the BALF was mark-
edly reduced in Nlrp3/ and Casp1/
animals compared to the wild-type.
However, Thomas et al. (2009) observed
a different pattern of lung histology in
Nlrp3/ animals than that observed by
Allen et al. (2009), in which there was an
increase in pulmonary necrosis and
collagen deposition in the lungs of
infected mice when compared to wild-
type animals. The reasons for the histo-
logic discrepancies between these
studies are unclear but could be caused
by specific differences between mouse
lines, given that the two groups used inde-
pendently constructed lines of Nlrp3/
mice. Although both groups agree that
NLRP3 protects mice from influenza
mortality, they also concluded that
disruption of inflammasome signaling
upon NLRP3 deletion did not impact the
generation of adaptive immunity against
influenza A virus. These results seeminglyImmunitdiffer from the observations of Ichinohe
et al. (2009), who showed that inflamma-
some-deficient mice had defective adap-
tive immune responses against influenza
A virus A/PR8 infection that were attrib-
uted to ASC, caspase 1, or overall IL-1
receptor signaling but not to NLRP3
becauseNlrp3/micewere not observed
to display increased susceptibility to
infection. The influenza A virus infection,
however, differed among the studies and
were conducted at a much lower dose
(ten plaque-forming units [Ichinohe et al.,
2009] versus 6000–8000 plaque forming
units [Allen et al., 2009; Thomas et al.,
2009]), suggesting that the protective
effects of NLRP3 vary with initial viral chal-
lenge dose and acute viral load.
To define the role of NLRP3 in virus-
induced inflammasome activity, Allen
et al. (2009) and Thomas et al. (2009)
each assessed the release of IL-1b, the
characteristic marker of inflammasome
activity. Similar to the findings of Ichinohe
et al. (2009), both groups demonstrate
that Nlrp3/ mice secrete substantially
less IL-1b into BALF upon influenza A
virus infection than wild-type mice. To
determine the effect of NLRP3 mediated
inflammasome defects in the adaptive
immune response against influenza A
virus, Thomas et al. (2009) examined
antigen-specific IgG or CD8+ T cell
response at 11 days after infection. In
agreement with the results of Ichinohe
et al. (2009), no marked defects in adap-
tive immunity were observed in Nlrp3/
animals. The work of Ichinohe et al.
(2009) suggested that macrophages and
dendritic cells, but not lung fibroblasts,
were the cells responsible for NLRP3-
dependent IL-1B production. Moreover,
Allen et al. (2009) showed that primary
human airway epithelial cultures could
also induce increased NLRP3 expres-
sion and produce IL-1b in response to
influenza A virus infection. Thus, both
epithelial cells and macrophages may
contribute to NLRP3 signaling during
infection. Prior work has suggested that
the common signal leading to NLRP3 acti-
vation could be deregulated lysosomal
function within infected cells (Hornung
et al., 2008), and such a function leads
to the leakage of lysosome contents into
the cytoplasm and/or the production of
reactive oxygen species (ROS) that trigger
inflammasome signaling. In agreement
with this hypothesis, Allen et al. (2009)y 30, April 17, 2009 ª2009 Elsevier Inc. 477
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PreviewsFigure 1. Influenza Activation of NLRP3 Inflammasome
Influenza A virus infects airway epithelial cells, macrophages, and dendritic cells in the lung (left). Viral RNA within an infected cell and/or virus debris taken up
by phagocytic cells leads to NLRP3 activation and inflammasome formation in a manner dependent on viral RNA-PRR interaction and/or lysosome function.
Caspase 1 in the inflammasome complex processes pro-IL-1b and pro-IL-18 into their mature, active forms (right). Increased IL-1b and IL-18 proinflammatory
cytokine secretion recruits monocytes and neutrophils into the lung to control infection and tissue pathogenesis (center).showed that influenza A virus-induced
IL-1b production in human monocytes
could be abrogated by blocking endo-
some acidification, thereby inhibiting the
lysosomal protease cathepsin B, or by
treatment with ROS inhibitors. Impor-
tantly, Thomas et al. (2009) and Allen
et al. (2009) also showed that double
stranded (ds) RNA could serve as the
signal for NLRP3 activation. However, it
is not known whether NLRP3 functions
as a PRR for dsRNA and influenza A
virus RNA.
These results lead to a model in which
influenza A virus is sensed either in respi-
ratory epithelial cells or macrophages at
early time points of infection leading to
NLRP3 signaling activation, IL-1b produc-
tion, and the recruitment of neutrophils
and monocytes to the site of infection
where they further secrete inflammatory
cytokines, engulf virus-infected cells,
and serve to control virus spread, contain
tissue pathology, and support respiratory
function (Figure 1). By this model, NLRP3
is directly or indirectly activated in
response to PRR engagement of viral
RNA. However, neither study has shown
that NLRP3 is an actual PRR in this478 Immunity 30, April 17, 2009 ª2009 Elsevcase, and the actual PRR that recognizes
dsRNA to activate NLRP3 remains to be
defined. This model also implies that
NLRP3 signaling is tightly controlled
because a high amount of systemic proin-
flammatory cytokines can enhance viral
pathogenesis by triggering a ‘‘cytokine
storm’’ that drives a massive and toxic
inflammatory response. Viral RNA is also
an important PAMP for type 1 interferon
induction, suggesting the potential for
signaling crosstalk between TLR, RLR,
and NLRP3 pathways. Indeed one
member of the NLR family, NLRX1, has
been identified as a key regulator the
RIG-I signaling pathway and also facili-
tates ROS production, suggesting a re-
gulatory connection of RLR and NLR
pathways (Meylan and Tschopp, 2008).
Further studies are required to under-
stand the relative contributions of TLR,
RLR, and NLR signaling in inflammation
and the inflammatory response to virus
infection.
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